3 Vaccine Stocks for the Next Decade
Over the last 18 months, COVID-19 has dominated the stock market in general, and vaccine stocks in particular. Companies and governments are trying to vaccinate as many people as possible to minimize the threat of this disease and maybe even eradicate it. That's the here and now, and any news can send vaccine stocks soaring, or crashing, overnight.
It's hard to imagine what the vaccine stocks will look like 10 years from now. Will COVID-19 still be in the headlines? Or will it recede in importance? A group of Fool contributors suggest you might want to buy shares of Moderna (NASDAQ: MRNA), Pfizer (NYSE: PFE), and Vir Biotechnology (NASDAQ: VIR). Here's why.
Image source: Getty Images.
Source Fool.com
